Achieve Life Sciences (ACHV) Receivables - Other (2011 - 2016)
Achieve Life Sciences' (ACHV) quarterly Receivables - Other came in at $32000.0 in Q4 2016, down 71.17% YoY from $111000.0 in Q1 2016, and down 11.11% on a QoQ basis from $36000.0 in Q3 2016.
Achieve Life Sciences (ACHV) Receivables - Other (2011 - 2016) Analysis & Trends
Achieve Life Sciences (ACHV) has 6 years of Receivables - Other data on file, last reported at $32000.0 in Q4 2016.
- Quarterly Receivables - Other fell 71.17% year-over-year to $32000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $32000.0 (down 71.17% YoY) and the FY2016 annual result came in at $32000.0, down 71.17% from the prior year.
- Receivables - Other declined to $32000.0 in Q4 2016, from $36000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $327000.0 in Q4 2012 to a low of $19000.0 in Q3 2014.
- A 5-year average of $139562.5 and a median of $93500.0 in 2015 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2014 — Receivables - Other plunged 93.56% — and 2015, when it surged 152.63%.
- Tracing ACHV's Receivables - Other over 5 years: stood at $327000.0 in 2012, then plunged by 33.33% to $218000.0 in 2013, then plunged by 48.17% to $113000.0 in 2014, then decreased by 1.77% to $111000.0 in 2015, then tumbled by 71.17% to $32000.0 in 2016.
- The last three Receivables - Other figures came in at $32000.0 (Q4 2016), $36000.0 (Q3 2016), and $47000.0 (Q2 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 32,000.00 |
| Dec 31, 2016 | 32,000.00 |
| Sep 30, 2016 | 36,000.00 |
| Sep 30, 2016 | 36,000.00 |
| Jun 30, 2016 | 47,000.00 |
| Jun 30, 2016 | 47,000.00 |
| Mar 31, 2016 | 53,000.00 |
| Mar 31, 2016 | 53,000.00 |
| Dec 31, 2015 | 111,000.00 |
| Dec 31, 2015 | 111,000.00 |
| Sep 30, 2015 | 48,000.00 |
| Sep 30, 2015 | 48,000.00 |
| Jun 30, 2015 | 76,000.00 |
| Jun 30, 2015 | 76,000.00 |
| Mar 31, 2015 | 71,000.00 |
| Mar 31, 2015 | 71,000.00 |
| Dec 31, 2014 | 113,000.00 |
| Dec 31, 2014 | 113,000.00 |
| Sep 30, 2014 | 19,000.00 |
| Sep 30, 2014 | 19,000.00 |